Drug Discovery Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Size, Opportunities, Segmentation and Forecast 2015 – 2021
Drug discovery and development are key functions of pharmaceutical and biotechnology companies. Drug discovery programs are essential for the introduction of new drugs. As more number of patients are diagnosed with new symptoms and syndromes. Drug discovery programs are usually lengthy and involve target identification, target validation, clinical trials, registration and approval. The whole process takes 15 years before the drug is officially launched and marketed. It is important for the governments to make their processes more coherent and less time consuming. Also, policies should be made to make data sharing more efficient. Drugs discovery should be made cheaper by relaxing tax laws, decreasing duties on instrument exports, increasing government and private funding. Introduction of new drugs and changes in the laws can lead to reduced cost and pricing of new target drugs.
At present North American companies have the highest market share in the overall drug discovery market. Major drug discovery technology and service providers are established in the U.S. The market is driven by presence of manufacturing facilities and research labs of major drug manufacturers. North America is also the highest consumer of branded drugs. The assistance of government regulatory bodies and high level of awareness related to life threatening diseases also encourage drug manufacturers to work on target drug discovery. Similar factors along with common regulations across Europe are responsible for a well developed market. European research labs and institutes are driven by favourable environment provided by the European Union. Chinese, Japanese and Indian companies are providing contract research services to major pharmaceutical companies in the West. China is the leading Asian country as major international pharmaceutical companies are building their manufacturing facilities in China.
Companies profiled include:
1. Sanofi
2. Johnson and Johnson
3. AstraZeneca
4. Bayer
5. BohringerIngheliem
6. Pfizer
7. GlaxoSmithKline
8. Eli Lily
9. Albany Molecular Research
10. Charles River Laboratories
11. Covance
12. Cyprotex
13. EVT innovate
14. Gen Script
15. Pharmaceutical Product Development
16. Quintiles
17. Viva Biotech
18. WIL research Laboratories
19. WUXI Apptech
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. In-depth profiling of companies
At present North American companies have the highest market share in the overall drug discovery market. Major drug discovery technology and service providers are established in the U.S. The market is driven by presence of manufacturing facilities and research labs of major drug manufacturers. North America is also the highest consumer of branded drugs. The assistance of government regulatory bodies and high level of awareness related to life threatening diseases also encourage drug manufacturers to work on target drug discovery. Similar factors along with common regulations across Europe are responsible for a well developed market. European research labs and institutes are driven by favourable environment provided by the European Union. Chinese, Japanese and Indian companies are providing contract research services to major pharmaceutical companies in the West. China is the leading Asian country as major international pharmaceutical companies are building their manufacturing facilities in China.
Companies profiled include:
1. Sanofi
2. Johnson and Johnson
3. AstraZeneca
4. Bayer
5. BohringerIngheliem
6. Pfizer
7. GlaxoSmithKline
8. Eli Lily
9. Albany Molecular Research
10. Charles River Laboratories
11. Covance
12. Cyprotex
13. EVT innovate
14. Gen Script
15. Pharmaceutical Product Development
16. Quintiles
17. Viva Biotech
18. WIL research Laboratories
19. WUXI Apptech
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. In-depth profiling of companies
1. INTRODUCTION
1.1. Executive Summary
1.2. Estimation Methodology
2. MARKET OVERVIEW
2.1. Key findings
2.2. Value Chain analysis
2.3. Key buying criteria
2.4. Drug Discovery Pipeline Process
2.4.1. Pre Discovery of target
2.4.2. Compound Discovery
2.4.3. Lead discovery and Optimization
2.4.4. Pre Clinical Study
2.4.5. Clinical Trials
2.4.6. Application/Approval
2.4.7. Manufacturing
2.4.8. Market launch and Market
2.5. Strategic recommendation
2.6. Strategic conclusions
2.7. Unit shipment in Drug Discovery market
2.8. Forecasted trends and emerging markets
3. MARKET DETERMINANTS
3.1. Market drivers
3.2. Market restraints
3.3. Market challenges
3.4. Market opportunities
4. MARKET SEGMENTATION
4.1. By Service
4.1.1. Biological Services
4.1.2. Chemical Services
4.1.3. Pharmaceutical Services
4.1.4. Drug Metabolism and Pharmacokinetics (DMPK) Services
4.2. By Science
4.2.1. Proteomics
4.2.2. Genomics
4.2.3. Bioinformatics
4.3. By technology
4.3.1. QPCR
4.3.2. DNA and protein microarrays
4.3.3. High-throughput screening
4.3.4. Mass spectrometry
4.3.5. Laboratory information management systems
4.3.6. Microfluidics
4.3.7. Gel electrophoresis
4.3.8. Chromatography
4.3.9. Protein and nucleic acid isolation.
4.3.10. Others
4.4. Novel technologies:
4.4.1. Back scattering interferometry
4.4.2. Cantilever array
5. MARKET SHARE AND STRATEGY
6. GEOGRAPHICAL ANALYSIS
6.1. North America
6.1.1. United States (U.S.)
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom (UK)
6.2.2. France
6.2.3. Germany
6.2.4. Spain
6.2.5. Italy
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Korea
6.3.5. Australia
6.4. Rest of the world
6.4.1. Latin America
6.4.2. MENA
6.4.3. Africa
7. COMPANY PROFILING:
7.1. Sanofi
7.2. Johnson and Johnson
7.3. AstraZeneca
7.4. Bayer
7.5. BohringerIngheliem
7.6. Pfizer
7.7. GlaxoSmithKline
7.8. Eli Lily
7.9. Albany Molecular Research
7.10. Charles River Laboratories
7.11. Covance
7.12. Cyprotex
7.13. EVT innovate
7.14. Gen Script
7.15. Pharmaceutical Product Development
7.16. Quintiles
7.17. Viva Biotech
7.18. WIL research Laboratories
7.19. WUXI Apptech
TABLE LIST
1. Global Drug discovery market by region, 2014-2021 (in $million)
2. Global Drug discovery market, by region, 2014-2021 (in $million)
3. Global qPCR Drug discovery market by region, 2014-2021 (in $million)
4. Global DNA microarray Drug discovery market, by region, 2014-2021 (in $million)
5. Global Protein microarray market, by region, 2014-2021 (in $million)
6. Global High throughput screening market, by region, 2014-2021 (in $million)
7. Global mass spectrometry market, by region, 2014-2021 (in $million)
8. Global gel electrophoresis market, by technology, 2014-2021 (in $million)
9. Global chromatography market by Geography in $million (2014-2020)
10. North America Drug discovery market, 2014-2021 (in $million)
11. Asia-Pacific Drug discovery market, 2014-2021 (in $million)
12. Europe Drug discovery market, 2014-2021 (in $million)
13. Rest of the world Drug discovery market, 2014-2021 (in $million)
FIGURE LIST
1. Market share Drug discovery market, 2014
2. Drug discovery Market share by region
3. Key buying criteria for Drug discovery.
4. US in Drug discovery, 2014-2021 (in $million)
5. Canada Drug discovery, 2014-2021 (in $million)
6. China Drug discovery, 2014-2021 (in $million)
7. India Drug discovery, 2014-2021 (in $million)
8. Japan Drug discovery, 2014-2021 (in $million)
9. Australia Drug discovery market, 2014-2021 (in $million)
10. South Korea Drug discovery, 2014-2021 (in $million)
11. United Kingdom Drug discovery market, 2014-2021 (in $million)
12. Italy Drug discovery market, 2014-2021 (in $million)
13. France Drug discovery market, 2014-2021 (in $million)
14. Germany Drug discovery market, 2014-2021 (in $million)
15. Spain Drug discovery market, 2014-2021 (in $million)
16. Latin America Drug discovery, 2014-2021 (in $million)
17. MENA Drug discovery market, 2014-2021 (in $million)
18. Africa Drug discovery market, 2014-2021 (in $million)
1.1. Executive Summary
1.2. Estimation Methodology
2. MARKET OVERVIEW
2.1. Key findings
2.2. Value Chain analysis
2.3. Key buying criteria
2.4. Drug Discovery Pipeline Process
2.4.1. Pre Discovery of target
2.4.2. Compound Discovery
2.4.3. Lead discovery and Optimization
2.4.4. Pre Clinical Study
2.4.5. Clinical Trials
2.4.6. Application/Approval
2.4.7. Manufacturing
2.4.8. Market launch and Market
2.5. Strategic recommendation
2.6. Strategic conclusions
2.7. Unit shipment in Drug Discovery market
2.8. Forecasted trends and emerging markets
3. MARKET DETERMINANTS
3.1. Market drivers
3.2. Market restraints
3.3. Market challenges
3.4. Market opportunities
4. MARKET SEGMENTATION
4.1. By Service
4.1.1. Biological Services
4.1.2. Chemical Services
4.1.3. Pharmaceutical Services
4.1.4. Drug Metabolism and Pharmacokinetics (DMPK) Services
4.2. By Science
4.2.1. Proteomics
4.2.2. Genomics
4.2.3. Bioinformatics
4.3. By technology
4.3.1. QPCR
4.3.2. DNA and protein microarrays
4.3.3. High-throughput screening
4.3.4. Mass spectrometry
4.3.5. Laboratory information management systems
4.3.6. Microfluidics
4.3.7. Gel electrophoresis
4.3.8. Chromatography
4.3.9. Protein and nucleic acid isolation.
4.3.10. Others
4.4. Novel technologies:
4.4.1. Back scattering interferometry
4.4.2. Cantilever array
5. MARKET SHARE AND STRATEGY
6. GEOGRAPHICAL ANALYSIS
6.1. North America
6.1.1. United States (U.S.)
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom (UK)
6.2.2. France
6.2.3. Germany
6.2.4. Spain
6.2.5. Italy
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Korea
6.3.5. Australia
6.4. Rest of the world
6.4.1. Latin America
6.4.2. MENA
6.4.3. Africa
7. COMPANY PROFILING:
7.1. Sanofi
7.2. Johnson and Johnson
7.3. AstraZeneca
7.4. Bayer
7.5. BohringerIngheliem
7.6. Pfizer
7.7. GlaxoSmithKline
7.8. Eli Lily
7.9. Albany Molecular Research
7.10. Charles River Laboratories
7.11. Covance
7.12. Cyprotex
7.13. EVT innovate
7.14. Gen Script
7.15. Pharmaceutical Product Development
7.16. Quintiles
7.17. Viva Biotech
7.18. WIL research Laboratories
7.19. WUXI Apptech
TABLE LIST
1. Global Drug discovery market by region, 2014-2021 (in $million)
2. Global Drug discovery market, by region, 2014-2021 (in $million)
3. Global qPCR Drug discovery market by region, 2014-2021 (in $million)
4. Global DNA microarray Drug discovery market, by region, 2014-2021 (in $million)
5. Global Protein microarray market, by region, 2014-2021 (in $million)
6. Global High throughput screening market, by region, 2014-2021 (in $million)
7. Global mass spectrometry market, by region, 2014-2021 (in $million)
8. Global gel electrophoresis market, by technology, 2014-2021 (in $million)
9. Global chromatography market by Geography in $million (2014-2020)
10. North America Drug discovery market, 2014-2021 (in $million)
11. Asia-Pacific Drug discovery market, 2014-2021 (in $million)
12. Europe Drug discovery market, 2014-2021 (in $million)
13. Rest of the world Drug discovery market, 2014-2021 (in $million)
FIGURE LIST
1. Market share Drug discovery market, 2014
2. Drug discovery Market share by region
3. Key buying criteria for Drug discovery.
4. US in Drug discovery, 2014-2021 (in $million)
5. Canada Drug discovery, 2014-2021 (in $million)
6. China Drug discovery, 2014-2021 (in $million)
7. India Drug discovery, 2014-2021 (in $million)
8. Japan Drug discovery, 2014-2021 (in $million)
9. Australia Drug discovery market, 2014-2021 (in $million)
10. South Korea Drug discovery, 2014-2021 (in $million)
11. United Kingdom Drug discovery market, 2014-2021 (in $million)
12. Italy Drug discovery market, 2014-2021 (in $million)
13. France Drug discovery market, 2014-2021 (in $million)
14. Germany Drug discovery market, 2014-2021 (in $million)
15. Spain Drug discovery market, 2014-2021 (in $million)
16. Latin America Drug discovery, 2014-2021 (in $million)
17. MENA Drug discovery market, 2014-2021 (in $million)
18. Africa Drug discovery market, 2014-2021 (in $million)
